{"id":64164,"date":"2023-07-14T16:39:51","date_gmt":"2023-07-14T11:09:51","guid":{"rendered":"http:\/\/finservwealth.com\/the-love-affair-continues-mfs-continue-betting-big-on-healthcare-stocks-in-june\/"},"modified":"2023-07-14T16:39:51","modified_gmt":"2023-07-14T11:09:51","slug":"the-love-affair-continues-mfs-continue-betting-big-on-healthcare-stocks-in-june","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/the-love-affair-continues-mfs-continue-betting-big-on-healthcare-stocks-in-june\/","title":{"rendered":"The love affair continues: MFs continue betting big on healthcare stocks in June"},"content":{"rendered":"<p> Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200.<\/p><div id=\"finse-982395135\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/the-love-affair-continues-mfs-continue-betting-bighealthcare-stocksjune_17113031.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200. Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/the-love-affair-continues-mfs-continue-betting-bighealthcare-stocksjune_17113031.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/the-love-affair-continues-mfs-continue-betting-bighealthcare-stocksjune_17113031.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200. Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/the-love-affair-continues-mfs-continue-betting-bighealthcare-stocksjune_17113031.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Ten out of 11 mutual fund houses covered by Nuvama Alternative  Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-64164","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/s\/sensex_nifty_sensex_market_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/64164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=64164"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/64164\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=64164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=64164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=64164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}